Heparin Sodium and Dextrose

Hospira, Inc.🇺🇸 United States

FDA Page

Effective Date: May 25, 2026
Approval ID: eede8a0c-5ae6-4166-84b3-12081405f08e
Products: 3 registered
Version: 35

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use HEPARIN SODIUM IN 5% DEXTROSE INJECTION safely and effectively. See full prescribing information for HEPARIN SODIUM IN 5% DEXTROSE INJECTION. HEPARIN SODIUM IN 5% DEXTROSE INJECTION, for intravenous useInitial U.S. Approval: 1939

Quick Stats

Total Products3

Labelers2

Label Sections38

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.